Recent medical study: New drug may help treat sleep apnea
A recent medical study has shown promising results for the use of the drug "tirzepatide," commercially known as "Mounjaro," in treating obstructive sleep apnea in people suffering from obesity.
This study is considered an important step in the medical field, as many people around the world, including in the Kingdom of Saudi Arabia, suffer from obesity problems and the subsequent respiratory disorders during sleep. Sleep apnea leads to a constant feeling of fatigue for the patient and affects their daily quality of life.
Researchers noted that the drug helped significantly improve the respiratory condition of the study participants. This treatment works by helping to lose excess weight, which reduces pressure on the airways during sleep and allows the patient to breathe normally.
Doctors confirm that these results open new horizons for treating obesity-related diseases. However, experts emphasize the necessity of consulting a specialist doctor before starting to use any new medications to ensure they are suitable for each individual's health condition.
This news comes at a time when the Kingdom of Saudi Arabia is paying great attention to developing health services and spreading awareness about the importance of combating obesity, as part of the Vision 2030 goals to improve the quality of life for citizens and residents.